Prosecution Insights
Last updated: October 04, 2026
Application No. 18/389,369

CATHETER WITH ENHANCED NAVIGABILITY TO AVOID OPHTHALMIC ARTERY

Non-Final OA §102§103
Filed
Nov 14, 2023
Examiner
RODJOM, KATHERINE MARIE
Art Unit
3771
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
NEURAVI Limited
OA Round
1 (Non-Final)
65%
Grant Probability
Favorable
1-2
OA Rounds
1y 5m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 65% — above average
65%
Career Allowance Rate
438 granted / 670 resolved
-4.6% vs TC avg
Strong +34% interview lift
Without
With
+34.5%
Interview Lift
resolved cases with interview
Typical timeline
4y 3m
Avg Prosecution
29 currently pending
Career history
697
Total Applications
across all art units

Statute-Specific Performance

§101
0.6%
-39.4% vs TC avg
§103
47.9%
+7.9% vs TC avg
§102
23.9%
-16.1% vs TC avg
§112
18.0%
-22.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 670 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of Invention I, claims 1-18, drawn to a catheter and Species A1 (Figs 7A-8) and B1 (Figs 2A-5C), encompassing claims 1-8 and 11-15, in the reply filed on June 15, 2026 is acknowledged. Claims 9-10 and 16-20 are withdrawn from further consideration pursuant to 37 CFR 1.142(b), as being drawn to a nonelected invention and species, there being no allowable generic or linking claim. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1-5 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Alaswad et al. (US 11,779,362, hereinafter “Alaswad”). Regarding claim 1, Alaswad discloses a catheter (Figs 12-18) comprising: an elongated body (1202) comprising a proximal end (1206), a distal end (see annotated Figs 14 and 16 below), a longitudinal axis, and an elongated body outer diameter; a tip (see annotated Figs 14 and 16 below) disposed at the distal end of the elongated body along the longitudinal axis, comprising: an opening (1230) comprising a tip outer diameter (at cross section A-A) smaller than the elongated body outer diameter (at cross section E-E); a neck (distal portion of tip; see annotated Figs 14 and 16 below for example) proximal of the opening comprising the tip outer diameter; and a shoulder (proximal portion of tip; see annotated Figs 14 and 16 below for example) disposed between the neck and the elongated body; a central lumen (1232) extending from the proximal end to the distal end along the longitudinal axis through the tip; and a bump (1210) extending longitudinally from the elongated body to proximate the opening and being partially circumferentially attached to at least a portion of the neck and the elongated body, forming an asymmetric cross section of the distal end (see annotated Figs 14 and 16 below). [AltContent: connector][AltContent: connector][AltContent: ][AltContent: ][AltContent: textbox (Tip)][AltContent: connector][AltContent: arrow][AltContent: connector][AltContent: ][AltContent: ][AltContent: textbox (Neck)][AltContent: textbox (Opening)][AltContent: textbox (Elongate body)] PNG media_image1.png 762 400 media_image1.png Greyscale [AltContent: ][AltContent: arrow] [AltContent: ][AltContent: textbox (Shoulder)] PNG media_image2.png 768 300 media_image2.png Greyscale Regarding claim 2, wherein the asymmetric cross section (cross-section of B-B or C-C) comprises an outer diameter greater than an average inner diameter of an ophthalmic artery to prevent the catheter from entering the ophthalmic artery (fully capable of being larger an average ophthalmic artery and preventing the catheter from entering the ophthalmic artery depending on the type of ophthalmic artery - for example infant, pediatric or smaller animal. It is noted the required dimensions are not recited). Regarding claim 3, wherein the outer diameter of the asymmetric cross section (cross-section of B-B or C-C) is smaller than an average inner diameter of a cerebral vessel to allow the catheter to go through the cerebral vessel (fully capable of being smaller than an average inner diameter of a cerebral vessel to allow the catheter to go through the cerebral vessel depending on the type of cerebral vessel – for example adult sized, diseased vessel, or larger animal. It is noted the required dimensions are not recited). Regarding claim 4, further comprising: a side lumen (1236) disposed within a sidewall of the catheter extending from the proximal end to the distal end along the longitudinal axis and exiting through the tip, configured to receive a guidewire (1240 or 1806). Regarding claim 5, wherein the central lumen (1232) comprises a uniform inner diameter (see Figs 14 and 16 above). Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim(s) 6 and 11-15 is/are rejected under 35 U.S.C. 103 as being unpatentable over Alaswad (US 11,779,362) in view of Sarabia (US 2021/0016062) Regarding claims 6, 11, and 12, Alaswad discloses a catheter (Figs 12-18), comprising: an elongated body comprising a proximal end (1206), a distal end (see annotated Figs 14 and 16 below), a longitudinal axis, and an elongated body outer diameter; a tip (see annotated Figs 14 and 16 above) disposed at the distal end of the elongated body along the longitudinal axis, comprising: an opening (1230) comprising a tip outer diameter (cross-section A-A) smaller than the elongated body outer diameter (cross section E-E); a neck (distal portion of tip; see annotated Figs 14 and 16 below for example) proximal of the opening comprising the tip outer diameter; and a shoulder (distal portion of tip; see annotated 14 and 16 below for example) disposed between the neck and the elongated body; a central lumen (1232) extending from the proximal end to the distal end along the longitudinal axis through the tip; and However, Alaswad fails to disclose the claimed sterling lumens. Sarabia discloses a similar catheter or sheath and teaches the benefit of providing a steering mechanism to facilitate accurate positioning of the catheter or sheath within the body (para [0005-0007]). In particular Sarabia teaches at least one, two, or four steering lumens (1460, 1480, 1500, or 1420) extending within a sidewall of the catheter from the proximal end to the distal end along the longitudinal axis through the tip, the at least one steering lumen being closed proximate the distal opening of the catheter (Fig 3B; para [0057]). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify Alaswad to include at least four steering lumens within the sidewall of the catheter, as taught by Sarabia, for the purpose of facilitating more accurate positioning of the catheter within the body. Regarding claim 13, Alaswad discloses the catheter further comprises: a side lumen (1236) disposed within a sidewall of the catheter extending from the proximal end to the distal end along the longitudinal axis and exiting through the tip, configured to receive a guidewire (1240 or 1806) (Fig 14). Regarding claim 14, Alaswad teaches the catheter further comprises a guidewire (1240 or 1806) incorporated within the side lumen (1236) (Fig 14). Regarding claim 15, Alaswad teaches the catheter further comprises: a side lumen (1236) disposed within a sidewall of the catheter extending from the proximal end to the distal end along the longitudinal axis and exiting through the shoulder (at port 1208), configured to receive a guidewire (1240 or 1806) (Fig 14). Claim(s) 6-8 and 13-15 is/are rejected under 35 U.S.C. 103 as being unpatentable over Alaswad (US 11,779,362) in view of Jones et al. (US 2021/0252254, hereinafter “Jones”). Regarding claims 6-8, Alaswad discloses a catheter (Figs 12-18), comprising: an elongated body comprising a proximal end (1206), a distal end (see annotated Figs 14 and 16 below), a longitudinal axis, and an elongated body outer diameter; a tip (see annotated Figs 14 and 16 above) disposed at the distal end of the elongated body along the longitudinal axis, comprising: an opening (1230) comprising a tip outer diameter (cross-section A-A) smaller than the elongated body outer diameter (cross section E-E); a neck (distal portion of tip; see annotated Figs 14 and 16 below for example) proximal of the opening comprising the tip outer diameter; and a shoulder (distal portion of tip; see annotated 14 and 16 below for example) disposed between the neck and the elongated body; a central lumen (1232) extending from the proximal end to the distal end along the longitudinal axis through the tip; and However, Alaswad fails to disclose the claimed sterling lumens. Jones discloses a similar catheter and teaches the benefit of providing a steering mechanism to improve the maneuverability of the catheter and thereby improve a physician’s ability to effectively orient the catheter (para [0005-0007]). In particular Jones teaches a catheter (Figs 5A-C) comprising at least one steering lumen (lumen 7100 for steering line 5700 isolated from primary interior lumen 5010 – Fig 7b; [0071]) extending within a sidewall of the catheter from the proximal end to the distal end along the longitudinal axis through the tip, the at least one steering lumen being closed proximate the distal opening of the catheter, wherein the at least one steering lumen comprises a steering lumen opening (5600) on a circumferential tip outer surface proximate the opening such that the opening extends substantially radially through the sidewall (Fig 5A; para [0065]). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify Alaswad to include a steering lumen with a steering lumen opening through the sidewall of the catheter, as taught by Jones, for the purpose of facilitating more accurate positioning of the catheter within the body. Regarding claim 13, Alaswad discloses the catheter further comprises: a side lumen (1236) disposed within a sidewall of the catheter extending from the proximal end to the distal end along the longitudinal axis and exiting through the tip, configured to receive a guidewire (1240 or 1806) (Fig 14). Regarding claim 14, Alaswad teaches the catheter further comprises a guidewire (1240 or 1806) incorporated within the side lumen (1236) (Fig 14). Regarding claim 15, Alaswad teaches the catheter further comprises: a side lumen (1236) disposed within a sidewall of the catheter extending from the proximal end to the distal end along the longitudinal axis and exiting through the shoulder (at port 1208), configured to receive a guidewire (1240 or 1806) (Fig 14). Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. US 2017/0296221 additionally discloses a catheter comprising an elongated body, tip having a neck and shoulder and opening having a smaller outer diameter than the elongated body outer diameter, and a bump, as claimed (Figs 2T-U). Any inquiry concerning this communication or earlier communications from the examiner should be directed to KATHERINE MARIE RODJOM whose telephone number is (571)272-3201. The examiner can normally be reached Monday - Thursday 8-5. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Elizabeth Houston can be reached at 571-272-7134. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /KATHERINE M RODJOM/Primary Examiner, Art Unit 3771
Read full office action

Prosecution Timeline

Nov 14, 2023
Application Filed
Aug 26, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12728001
Stabilizer For A Medical Delivery System
2y 0m to grant Granted Sep 08, 2026
Patent 12728071
REMOTE COLLABORATIVE ROBOT ACUPUNCTURE SYSTEM
1y 1m to grant Granted Sep 08, 2026
Patent 12702436
ENDOSCOPIC TRANSLUMINAL STENT ACCESS AND DELIVERY SYSTEM
3y 6m to grant Granted Aug 11, 2026
Patent 12678191
ANCHOR FOR TRANSCATHETER ACCESS INTO THE CORONARY SINUS
4y 8m to grant Granted Jul 14, 2026
Patent 12672878
MEDICAL DEVICES FOR TREATING A TARGET SITE AND ASSOCIATED METHOD
5y 10m to grant Granted Jul 07, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
65%
Grant Probability
99%
With Interview (+34.5%)
4y 3m (~1y 5m remaining)
Median Time to Grant
Low
PTA Risk
Based on 670 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month